Characterization of SARS-CoV Main Protease and Identification of Biologically Active Small Molecule Inhibitors Using a Continuous Fluorescence-Based Assay

FEBS Letters - United States
doi 10.1016/j.febslet.2004.09.026
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley-Blackwell

Related search

An Overview of Severe Acute Respiratory SyndromeCoronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

English

In Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors

2020English

A Sensitive Aβ Oligomerization Assay for Identification of Small Molecule Inhibitors

Open Biotechnology Journal
BiochemistryBiotechnologyBiophysicsBiomedical EngineeringBioengineering
2009English

Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study

2020English

Identification and Biochemical Characterization of Small-Molecule Inhibitors of West Nile Virus Serine Protease by a High-Throughput Screen

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Variable Structural Networks at the Active Site of the SARS-CoV and SARS-CoV2 Main Proteases

2020English

Identification of Potent and Compartment-Selective Small Molecule Furin Inhibitors Using Cell-Based Assays

Biochemical Pharmacology
BiochemistryPharmacology
2015English

Inhibition of SARS-CoV 3CL Protease by Flavonoids

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2019English

Identification of Small Molecule Inhibitors Targeting the SMARCA2 Bromodomain From a High-Throughput Screening Assay

Acta Pharmacologica Sinica
MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy